Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma
- PMID: 23762823
- PMCID: PMC3674644
- DOI: 10.1155/2013/136106
Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma
Abstract
Hepatocellular carcinoma (HCC) is a leading cause of cancer death in many Asian and African countries. Lack of early diagnosis tools is one of the clinical obstacles for effective treatment of HCC. Thus, enhanced understanding of the molecular changes associated with HCC is urgently needed to develop novel strategies for the diagnosis and treatment of this dismal disease. While aberrant expression of long noncoding RNAs (lncRNAs) has been functionally associated with certain cancers, the expression profiles and biological relevance of lncRNAs in HCC remain unclear. Highly upregulated in liver cancer (HULC) lncRNA has been implicated in the regulation of hepatoma cell proliferation. In this study, we demonstrate that HULC expression is significantly higher in HCC tumors compared to normal liver tissues. Among the tumor tissues, higher HULC expression is positively associated with Edmondson histological grades or with hepatitis B (HBV) positive status. Moreover, HULC lncRNA is detected with higher frequency in the plasma of HCC patients compared to healthy controls. Higher HULC detection rates are observed in the plasma of patients with higher Edmondson grades or with HBV+ status. These findings indicate for the first time that the expression of HULC in plasma can be used as a noninvasive promising novel biomarker for the diagnosis and/or prognosis of HCC.
Figures


Similar articles
-
The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.J Cell Biochem. 2019 Sep;120(9):14645-14656. doi: 10.1002/jcb.28726. Epub 2019 Apr 22. J Cell Biochem. 2019. PMID: 31009106
-
A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma.Dis Markers. 2020 Jul 13;2020:5417598. doi: 10.1155/2020/5417598. eCollection 2020. Dis Markers. 2020. PMID: 32733618 Free PMC article.
-
HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma.Cell Physiol Biochem. 2015;37(2):687-96. doi: 10.1159/000430387. Epub 2015 Sep 11. Cell Physiol Biochem. 2015. PMID: 26356260
-
Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma.Cell Physiol Biochem. 2015;36(2):423-34. doi: 10.1159/000430109. Epub 2015 May 11. Cell Physiol Biochem. 2015. PMID: 25968300 Review.
-
Involvement of long non-coding RNA HULC (highly up-regulated in liver cancer) in pathogenesis and implications for therapeutic intervention.Expert Opin Ther Targets. 2019 Mar;23(3):177-186. doi: 10.1080/14728222.2019.1570499. Epub 2019 Jan 24. Expert Opin Ther Targets. 2019. PMID: 30678498 Review.
Cited by
-
Non-coding RNA and hepatitis B virus-related hepatocellular carcinoma: A bibliometric analysis and systematic review.Front Med (Lausanne). 2022 Sep 20;9:995943. doi: 10.3389/fmed.2022.995943. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36203765 Free PMC article.
-
Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls.Oncotarget. 2016 Oct 25;7(43):70769-70778. doi: 10.18632/oncotarget.12220. Oncotarget. 2016. PMID: 27683121 Free PMC article.
-
Upregulation of Long Noncoding RNA GAS5 Inhibits Lung Cancer Cell Proliferation and Metastasis via miR-205/PTEN Axis.Med Sci Monit. 2019 Mar 30;25:2311-2319. doi: 10.12659/MSM.912581. Med Sci Monit. 2019. PMID: 30926767 Free PMC article.
-
Long non-coding RNAs and hepatocellular carcinoma.Mol Clin Oncol. 2015 Jan;3(1):13-17. doi: 10.3892/mco.2014.429. Epub 2014 Sep 25. Mol Clin Oncol. 2015. PMID: 25469263 Free PMC article.
-
Linc-ing Circulating Long Non-coding RNAs to the Diagnosis and Malignant Prediction of Intraductal Papillary Mucinous Neoplasms of the Pancreas.Sci Rep. 2017 Sep 5;7(1):10484. doi: 10.1038/s41598-017-09754-5. Sci Rep. 2017. PMID: 28874676 Free PMC article.
References
-
- Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. The Oncologist. 2010;15(supplement 4):5–13. - PubMed
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. 2010;127(12):2893–2917. - PubMed
-
- Bertone P, Stolc V, Royce TE, et al. Global identification of human transcribed sequences with genome tiling arrays. Science. 2004;306(5705):2242–2246. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical